Aukning öndunarfæraeinkenna og notkunar astmalyfja meðal Íslendinga á aldrinum 20-44 ára
In the year 1990 the European Community Respiratory Health Survey I (ECRHS I) demonstrated that the prevalence of these diseases was lowest in Iceland (www.ecrhs.org). In order to compare the prevalence of respiratory symptoms in Reykjavik over time, a new identical cross-sectional study was perform...
Main Authors: | , , , |
---|---|
Format: | Article in Journal/Newspaper |
Language: | Icelandic |
Published: |
Læknafélag Íslands, Læknafélag Reykjavíkur
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/2336/146559 |
id |
ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/146559 |
---|---|
record_format |
openpolar |
spelling |
ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/146559 2023-05-15T16:50:01+02:00 Aukning öndunarfæraeinkenna og notkunar astmalyfja meðal Íslendinga á aldrinum 20-44 ára [Prevalence of respiratory symptoms and use of asthma drugs are increasing among young adult Icelanders] Stefán Sigurkarlsson Michael Clausen Þórarinn Gíslason Davíð Gíslason 2011-10-24 http://hdl.handle.net/2336/146559 ice is ice Læknafélag Íslands, Læknafélag Reykjavíkur http://www.laeknabladid.is/ Læknablaðið 2011, 97 (9):463-7 0023-7213 21911911 http://hdl.handle.net/2336/146559 Læknablaðið Asma Öndunarfærasjúkdómar Lyfjanotkun Adult Age Factors Anti-Asthmatic Agents Asthma Cross-Sectional Studies Drug Utilization Female Humans Iceland Male Physician's Practice Patterns Prevalence Questionnaires Time Factors Treatment Outcome Young Adult Article 2011 ftlandspitaliuni 2022-05-29T08:21:45Z In the year 1990 the European Community Respiratory Health Survey I (ECRHS I) demonstrated that the prevalence of these diseases was lowest in Iceland (www.ecrhs.org). In order to compare the prevalence of respiratory symptoms in Reykjavik over time, a new identical cross-sectional study was performed seventeen years later. Both cohorts, were in the age group 20-44 years and randomly selected from the population in Reykjavik and suburbs. Both answered questionnaires about respiratory symptoms, nasal allergy and use of anti-asthmatic drugs. The second cohort was part of the EuroPrevall study (www.europrevall.org) performed in 2007. Response rate was lower in 2007 (999 or 43.2%) than in 1990 (2.903 or 80.6%).The prevalence of attacks of asthma increased over time from 2.2% to 6.7% (p<0.0001), use of anti-asthmatic drugs increased from 2.4% to 7.2% (p<0.0001) and nasal allergy symptoms from 17.8% to 29.3% (p< 0.0001). There was an increase of all respiratory symptoms except wheezing or whistling, where the prevalence dropped from 18.0% to 14.4% (p<0.01). In the year 2007 women had more often been woken by attacks of coughing (p<0.0001), had more often attacks of asthma (p<0.05) and were more likely to use anti-asthmatic drugs (p<0.05) than men. Attacks of asthma and the use of anti-asthmatic drugs were more common among the younger age group in the year 2007. That was not seen in the year 1990. This study provides evidence of an increase in respiratory symptoms and use of anti-asthmatic drugs over a period of 17 years from 1990 among young adult Icelanders. Inngangur: Við samanburð milli 15 þjóða í Evrópurannsókninni Lungu og heilsa (ECRHS I) árið 1990 reyndist vera minnst um ofnæmissjúkdóma á Íslandi. Í þessari rannsókn eru niðurstöður tveggja þverskurðarrannsókna bornar saman til þess að meta hvort öndunarfæraeinkenni og notkun astmalyfja hafi aukist á Íslandi á 17 ára tímabili frá 1990. Efniviður og aðferðir: Rannsóknarhóparnir voru á aldrinum 20-44 ára og valdir af handahófi á ... Article in Journal/Newspaper Iceland Hirsla - Landspítali University Hospital research archive |
institution |
Open Polar |
collection |
Hirsla - Landspítali University Hospital research archive |
op_collection_id |
ftlandspitaliuni |
language |
Icelandic |
topic |
Asma Öndunarfærasjúkdómar Lyfjanotkun Adult Age Factors Anti-Asthmatic Agents Asthma Cross-Sectional Studies Drug Utilization Female Humans Iceland Male Physician's Practice Patterns Prevalence Questionnaires Time Factors Treatment Outcome Young Adult |
spellingShingle |
Asma Öndunarfærasjúkdómar Lyfjanotkun Adult Age Factors Anti-Asthmatic Agents Asthma Cross-Sectional Studies Drug Utilization Female Humans Iceland Male Physician's Practice Patterns Prevalence Questionnaires Time Factors Treatment Outcome Young Adult Stefán Sigurkarlsson Michael Clausen Þórarinn Gíslason Davíð Gíslason Aukning öndunarfæraeinkenna og notkunar astmalyfja meðal Íslendinga á aldrinum 20-44 ára |
topic_facet |
Asma Öndunarfærasjúkdómar Lyfjanotkun Adult Age Factors Anti-Asthmatic Agents Asthma Cross-Sectional Studies Drug Utilization Female Humans Iceland Male Physician's Practice Patterns Prevalence Questionnaires Time Factors Treatment Outcome Young Adult |
description |
In the year 1990 the European Community Respiratory Health Survey I (ECRHS I) demonstrated that the prevalence of these diseases was lowest in Iceland (www.ecrhs.org). In order to compare the prevalence of respiratory symptoms in Reykjavik over time, a new identical cross-sectional study was performed seventeen years later. Both cohorts, were in the age group 20-44 years and randomly selected from the population in Reykjavik and suburbs. Both answered questionnaires about respiratory symptoms, nasal allergy and use of anti-asthmatic drugs. The second cohort was part of the EuroPrevall study (www.europrevall.org) performed in 2007. Response rate was lower in 2007 (999 or 43.2%) than in 1990 (2.903 or 80.6%).The prevalence of attacks of asthma increased over time from 2.2% to 6.7% (p<0.0001), use of anti-asthmatic drugs increased from 2.4% to 7.2% (p<0.0001) and nasal allergy symptoms from 17.8% to 29.3% (p< 0.0001). There was an increase of all respiratory symptoms except wheezing or whistling, where the prevalence dropped from 18.0% to 14.4% (p<0.01). In the year 2007 women had more often been woken by attacks of coughing (p<0.0001), had more often attacks of asthma (p<0.05) and were more likely to use anti-asthmatic drugs (p<0.05) than men. Attacks of asthma and the use of anti-asthmatic drugs were more common among the younger age group in the year 2007. That was not seen in the year 1990. This study provides evidence of an increase in respiratory symptoms and use of anti-asthmatic drugs over a period of 17 years from 1990 among young adult Icelanders. Inngangur: Við samanburð milli 15 þjóða í Evrópurannsókninni Lungu og heilsa (ECRHS I) árið 1990 reyndist vera minnst um ofnæmissjúkdóma á Íslandi. Í þessari rannsókn eru niðurstöður tveggja þverskurðarrannsókna bornar saman til þess að meta hvort öndunarfæraeinkenni og notkun astmalyfja hafi aukist á Íslandi á 17 ára tímabili frá 1990. Efniviður og aðferðir: Rannsóknarhóparnir voru á aldrinum 20-44 ára og valdir af handahófi á ... |
format |
Article in Journal/Newspaper |
author |
Stefán Sigurkarlsson Michael Clausen Þórarinn Gíslason Davíð Gíslason |
author_facet |
Stefán Sigurkarlsson Michael Clausen Þórarinn Gíslason Davíð Gíslason |
author_sort |
Stefán Sigurkarlsson |
title |
Aukning öndunarfæraeinkenna og notkunar astmalyfja meðal Íslendinga á aldrinum 20-44 ára |
title_short |
Aukning öndunarfæraeinkenna og notkunar astmalyfja meðal Íslendinga á aldrinum 20-44 ára |
title_full |
Aukning öndunarfæraeinkenna og notkunar astmalyfja meðal Íslendinga á aldrinum 20-44 ára |
title_fullStr |
Aukning öndunarfæraeinkenna og notkunar astmalyfja meðal Íslendinga á aldrinum 20-44 ára |
title_full_unstemmed |
Aukning öndunarfæraeinkenna og notkunar astmalyfja meðal Íslendinga á aldrinum 20-44 ára |
title_sort |
aukning öndunarfæraeinkenna og notkunar astmalyfja meðal íslendinga á aldrinum 20-44 ára |
publisher |
Læknafélag Íslands, Læknafélag Reykjavíkur |
publishDate |
2011 |
url |
http://hdl.handle.net/2336/146559 |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
http://www.laeknabladid.is/ Læknablaðið 2011, 97 (9):463-7 0023-7213 21911911 http://hdl.handle.net/2336/146559 Læknablaðið |
_version_ |
1766040197534842880 |